FDA Safety Committees will examine the risks of Yasmin/Yaz/Beyaz as compared...
Two FDA Safety Committees will hold public meetings about the risks of Yaz on December 8, 2011. The two committees to meet are (1) the 13-member Reproductive Health Drugs Advisory Committee and (2) the...
View ArticleMore Evidence that Yaz carries an increased risk of VTE
The FDA posted the results of its much anticipated large retrospective study about the risk of venous thrombotic events (VTEs) and newer contraceptives containing drosperinone (DRSP) such as...
View ArticleNew Dutch Study Shows Yaz has Greater VTE Risk
A Dutch research team has published a new study concluding that Yaz has a greater risk of causing blood clots than other birth control pills. The Dutch cohort study looked at over one million women...
View Article
More Pages to Explore .....